Abstract
Purpose Development of a human mitochondrial gene delivery vector is a critical step in the ability to treat diseases arising from mutations in mitochondrial DNA. Although we have previously cloned the mouse mitochondrial genome in its entirety and developed it as a mitochondrial gene therapy vector, the human mitochondrial genome has been dubbed unclonable in E. coli, due to regions of instability in the D-loop and tRNAThr gene. Methods We tested multi- and single-copy vector systems for cloning human mitochondrial DNA in E. coli and Saccharomyces cerevisiae, including transformation-associated recombination. Results Human mitochondrial DNA is unclonable in E. coli and cannot be retained in multi- or single-copy vectors under any conditions. It was, however, possible to clone and stably maintain the entire human mitochondrial genome in yeast as long as a single-copy centromeric plasmid was used. D-loop and tRNAThr were both stable and unmutated. Conclusions This is the first report of cloning the entire human mitochondrial genome and the first step in developing a gene delivery vehicle for human mitochondrial gene therapy. © Springer Science+Business Media, LLC 2011.
Original language | English |
---|---|
Pages (from-to) | 2863-2870 |
Number of pages | 7 |
Journal | Pharmaceutical Research |
Volume | 28 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2011 |
Keywords
- Gene therapy
- Human mitochondrial DNA
- Mitochondrial disease
- Unclonable
- Yeast